Skip to main content
SpringerLink
Log in

A review of the applications of physiologically based pharmacokinetic modeling

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The physiological pharmacokinetic approach to the modeling of drug distribution is reviewed. These models allow extrapolation outside the range of data with some confidence if the dominant mechanisms of transport are sufficiently well understood. In addition, it is possible to extrapolate to other species. Compartments correspond to anatomical spaces so that biochemical interactions (including drug effect or pharmacodynamics) can be incorporated in the model. The articles summarized in this review are limited to models dealing with drug application.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. T. Teorell. Kinetics of distribution of substances administered to the body.Arch. Intern. Pharmacodyn. 57:205–240 (1937).

    CAS  Google Scholar 

  2. J. A. Jacques, R. Bellman, and R. Kabala. Some mathematical aspects of chemotherapy. I. One organ models.Bull. Math. Biophys. 22:309–322 (1960).

    Article  Google Scholar 

  3. R. L. Dedrick and K. B. Bischoff. Pharmacokinetics in applications of the artificial kidney.Chem. Eng. Progr. Symp. Ser. 64:32–44 (1968).

    CAS  Google Scholar 

  4. K. B. Bischoff and R. L. Dedrick. Thiopental pharmacokinetics.J. Pharm. Sci. 57:1346–1351 (1968).

    Article  CAS  PubMed  Google Scholar 

  5. R. L. Dedrick, D. D. Forrester, and K. H. W. Ho.In vitro-in vivo correlation of drug metabolism—Deamination of 1-D-arabinofuranosylcytosine.Biochem. Pharmacol. 21:1–16 (1972).

    Article  CAS  PubMed  Google Scholar 

  6. R. L. Dedrick, D. D. Forrester, J. N. Cannon, S. M. El Dareer, and L. B. Mellett. Pharmacokinetics of 1-Β-D-arabinofuranosylcytosine (Ara-C) deamination in several species.Biochem. Pharmacol. 22:2405–2417 (1973).

    Article  CAS  PubMed  Google Scholar 

  7. P. F. Morrison, T. L. Lincoln, and J. Aroesty. Disposition of cytosine arabinoside and its metabolites: A pharmacokinetic simulation.Cancer Treat. Rep. 59:861–876 (1975).

    CAS  Google Scholar 

  8. K. J. Himmelstein and J. F. Gross. Mathematical model for cyclocytidine pharmacokinetics.J. Pharm. Sci. 66:1441–1444 (1977).

    Article  CAS  PubMed  Google Scholar 

  9. R. J. Lutz, W. M. Galbraith, R. L. Dedrick, R. Shrager, and L. B. Mellett. A model for the kinetics of distribution of actinomycin-D in the beagle dog.J. Pharmacol. Exp. Ther. 200:469–478 (1977).

    CAS  PubMed  Google Scholar 

  10. L. Tterlikkis, E. Ortega, R. Solomon, and J. L. Day. Pharmacokinetics of mercaptopurine.J. Pharm. Sci. 66:1454–1457 (1977).

    Article  CAS  PubMed  Google Scholar 

  11. K. B. Bischoff, R. L. Dedrick, D. S. Zaharko, and J. A. Longstreth. Methotrexate pharmacokinetics.J. Pharm. Sci. 60:1128–1133 (1971).

    Article  CAS  PubMed  Google Scholar 

  12. B. Montandon, R. J. Roberts, and L. J. Fischer. Computer simulation of sulfobromophthalein kinetics in the rat using flow-limited models with extrapolation to man.J. Pharmacokin. Biopharm. 3:277–299 (1975).

    Article  CAS  Google Scholar 

  13. C. N. Chen, D. L. Coleman, J. D. Andrade, and A. R. Temple. Pharmacokinetic model for salicylate in cerebrospinal fluid, blood, organs and tissues.J. Pharm. Sci. 67:38 (1978).

    Article  CAS  PubMed  Google Scholar 

  14. N. Benowitz, R. P. Forsyth, K. C. Melmon, and M. M. Rowland. Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model.Clin. Pharmacol. Ther. 16:87–109 (1977).

    Google Scholar 

  15. P. A. Harris and J. F. Gross. Preliminary pharmacokinetic model for adriamycin.Cancer Chemother. Rep. 54:819–825 (1975).

    Google Scholar 

  16. L. I. Harrison and M. Gibaldi. Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat.J. Pharm. Sci. 66:1138–1142 (1977).

    Article  CAS  PubMed  Google Scholar 

  17. R. L. Dedrick, D. S. Zaharko, and R. J. Lutz. Transport and binding of methotrexate.in vivo. J. Pharm. Sci. 62:882–890 (1973).

    Article  CAS  PubMed  Google Scholar 

  18. R. J. Lutz, R. L. Dedrick, J. A. Straw, M. M. Hart, P. Klubes, and D. S. Zaharko. The kinetics of methotrexate distribution in spontaneous canine lymphosarcoma.J. Pharmacokin. Biopharm. 3:77–97 (1975).

    Article  CAS  Google Scholar 

  19. R. L. Dedrick, D. S. Zaharko, R. A. Bender, W. A. Bleyer, and R. J. Lutz. Pharmacokinetic considerations on resistance to anticancer drugs.Cancer Chemother. Rep. 59:795–804 (1975).

    CAS  PubMed  Google Scholar 

  20. R. L. Dedrick, C. E. Myers, P. M. Bungay, and V. T. DeVita. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.Cancer Treat. Rep. 62:1–11 (1978).

    CAS  PubMed  Google Scholar 

  21. K. B. Bischoff, R. L. Dedrick, and D. S. Zaharko. Preliminary model for methotrexate pharmacokinetics.J. Pharm. Sci. 59:149–154 (1970).

    Article  CAS  PubMed  Google Scholar 

  22. R. L. Dedrick and D. D. Forrester. Blood flow limitations in interpreting Michaelis constants for ethanol oxidationin vivo.Biochem. Pharmacol. 22:1133–1140 (1973).

    Article  CAS  PubMed  Google Scholar 

  23. K. B. Bischoff and R. G. Brown. Drug distribution in mammals.Chem. Eng. Progr. Symp. Ser. 62:32–45 (1966).

    Google Scholar 

  24. D. S. Greene, R. Quintiliani, and C. H. Nightinggale. Physiological perfusion model for cephalosporin antibiotics I: Model selection based on blood drug concentrations.J. Pharm. Sci. 67:191–196 (1978).

    Article  CAS  PubMed  Google Scholar 

  25. P. M. Bungay, R. L. Dedrick, and A. M. Guarino. Pharmacokinetic modeling of the dogfish shark: Distribution and urinary and biliary excretion of phenol red and its glucuronide.J. Pharmacokin. Biopharm. 4:377–388 (1976).

    Article  CAS  Google Scholar 

  26. R. J. Lutz, R. L. Dedrick, H. B. Matthews, T. E. Eling, and M. W. Anderson. A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat.Drug Metab. Disp. 5:386–396 (1977).

    CAS  Google Scholar 

  27. K. J. Himmelstein, I. Guvenir, and T. F. Patton. Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye.J. Pharm. Sci. 67:603–606 (1978).

    Article  CAS  PubMed  Google Scholar 

  28. J. A. Longstreth. Simulation of cellular response to methotrexate: Effects of membrane transport, enzyme synthesis, and cytokinetics. InProceedings of the 1976 Summer Computer Simulation Conference, Washington, D.C., July 12–14, AFIPS Press, Montvale, N.J., 1976.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemical and Petroleum Engineering, The University of Kansas, 66045, Lawrence, Kansas

    K. J. Himmelstein

  2. Biomedical Engineering and Instrumentation Branch, National Institutes of Health, 20014, Bethesda, Maryland

    R. J. Lutz

Authors
  1. K. J. Himmelstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. J. Lutz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Himmelstein, K.J., Lutz, R.J. A review of the applications of physiologically based pharmacokinetic modeling. Journal of Pharmacokinetics and Biopharmaceutics 7, 127–145 (1979). https://doi.org/10.1007/BF01059734

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01059734

Key words

Search

Navigation